Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2008
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial
John M S Bartlett, Alison Munro, David A Cameron, et al.
Gene
|
July 1, 2004
Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT)
Lubna Nasir, Elizabeth Gault, Sarah Campbell, et al.
International Journal of Environmental Research and Public Health
|
August 27, 2021
Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19
Alison Munro, Hazel Booth, Nicola M Gray, et al.
The International Journal on Drug Policy
|
February 8, 2018
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Heather Valerio, Andrew McAuley, Hamish Innes, et al.
Plos One
|
March 20, 2012
Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program
Aima A Ahonkhai, Farzad Noubary, Alison Munro, et al.
Addiction (Abingdon, England)
|
May 22, 2018
Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland
Hannah Fraser, Christinah Mukandavire, Natasha K Martin, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 27, 2011
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count
Bingxia Wang, Elena Losina, Ruth Stark, et al.
Plos One
|
August 12, 2014
Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions
Norah E Palmateer, Avril Taylor, David J Goldberg, et al.
Molecular Oncology
|
December 2, 2021
Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment
John C Dawson, Alison Munro, Kenneth Macleod, et al.
Breast Cancer Research and Treatment
|
November 2, 2011
Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial
Kathleen I Pritchard, Alison Munro, Frances P O'Malley, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2008
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial
John M S Bartlett, Alison Munro, David A Cameron, et al.
Gene
|
July 1, 2004
Isolation and expression of the reverse transcriptase component of the Canis familiaris telomerase ribonucleoprotein (dogTERT)
Lubna Nasir, Elizabeth Gault, Sarah Campbell, et al.
International Journal of Environmental Research and Public Health
|
August 27, 2021
Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19
Alison Munro, Hazel Booth, Nicola M Gray, et al.
The International Journal on Drug Policy
|
February 8, 2018
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Heather Valerio, Andrew McAuley, Hamish Innes, et al.
Plos One
|
March 20, 2012
Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program
Aima A Ahonkhai, Farzad Noubary, Alison Munro, et al.
Addiction (Abingdon, England)
|
May 22, 2018
Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland
Hannah Fraser, Christinah Mukandavire, Natasha K Martin, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 27, 2011
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count
Bingxia Wang, Elena Losina, Ruth Stark, et al.
Plos One
|
August 12, 2014
Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions
Norah E Palmateer, Avril Taylor, David J Goldberg, et al.
Molecular Oncology
|
December 2, 2021
Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment
John C Dawson, Alison Munro, Kenneth Macleod, et al.
Breast Cancer Research and Treatment
|
November 2, 2011
Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial
Kathleen I Pritchard, Alison Munro, Frances P O'Malley, et al.
Page
of 4